Reanalysis of BRCA1/2 Negative High Risk Ovarian Cancer Patients Reveals Novel Germline Risk Loci and Insights Into Missing Heritability

PLoS ONE - United States
doi 10.1371/journal.pone.0178450
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

BRCA1/2-negative, High-Risk Breast Cancers (BRCAX) for Asian Women: Genetic Susceptibility Loci and Their Potential Impacts

Scientific Reports
Multidisciplinary
2018English

RAD50 Germline Mutations Are Associated With Poor Survival in BRCA1/2 -Negative Breast Cancer Patients

International Journal of Cancer
Cancer ResearchOncology
2018English

Spectrum and Characterisation of BRCA1 and BRCA2deleterious Mutations in High-Risk Czech Patients With Breast and/or Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

Large BRCA1 and BRCA2 Genomic Rearrangements in Danish High Risk Breast-Ovarian Cancer Families

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Heterogeneity of Germline Variants in High Risk Breast and Ovarian Cancer Susceptibility Genes in India

Precision Clinical Medicine
2018English

Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

Annals of Surgical Oncology
OncologySurgery
2017English

Latest Insights Into the Risk of Cancer in Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2013English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Oral Contraceptive Use and Ovarian Cancer Risk Among Carriers of BRCA1 or BRCA2 Mutations

British Journal of Cancer
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy